Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Metz

Showing results (101-110 of 258) with videos related to

Pageof 26
Sort By:
The Journal of Allergy and Clinical Immunology|October 13, 2018
Real-life treatment of cholinergic urticaria with omalizumabSabine Altrichter, Mati Chuamanochan, Henriette Knoth, et al.
The Journal of Clinical Investigation|September 2, 2011
T cell killing by tolerogenic dendritic cells protects mice from allergyUlrike Luckey, Marcus Maurer, Talkea Schmidt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 4, 2019
Effective treatment of a lymphocytic variant of hypereosinophilic syndrome with reslizumabThomas Buttgereit, Hanna Bonnekoh, Martin K Church, et al.
Skin Pharmacology and Physiology|October 26, 2020
Flare Size but Not Intensity Reflects Histamine-Induced ItchSylwia Lehmann, Elyne Deuring, Karsten Weller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Mast Cells Limit the Exacerbation of Chronic Allergic Contact Dermatitis in Response to Repeated Allergen ExposureVladimir-Andrey Gimenez-Rivera, Frank Siebenhaar, Carolin Zimmermann, et al.
Nature Reviews. Disease Primers|September 15, 2022
UrticariaPavel Kolkhir, Ana M Giménez-Arnau, Kanokvalai Kulthanan, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2023
The 7-day recall period version of the Urticaria Control Test-UCT7Thomas Buttgereit, Pascale Salameh, Olga Sydorenko, et al.
Clinical and Experimental Medicine|August 9, 2023
An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphomaMan Hu, Jörg Scheffel, Daniel Elieh-Ali-Komi, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2014
The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticariaTse Wen Chang, Christina Chen, Chien-Jen Lin, et al.
Immunological Reviews|May 15, 2007
Mast cells in the promotion and limitation of chronic inflammationMartin Metz, Michele A Grimbaldeston, Susumu Nakae, et al.
Pageof 26

Showing results (101-110 of 258) with videos related to

Sort By:
Pageof 26
The Journal of Allergy and Clinical Immunology|October 13, 2018
Real-life treatment of cholinergic urticaria with omalizumabSabine Altrichter, Mati Chuamanochan, Henriette Knoth, et al.
The Journal of Clinical Investigation|September 2, 2011
T cell killing by tolerogenic dendritic cells protects mice from allergyUlrike Luckey, Marcus Maurer, Talkea Schmidt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 4, 2019
Effective treatment of a lymphocytic variant of hypereosinophilic syndrome with reslizumabThomas Buttgereit, Hanna Bonnekoh, Martin K Church, et al.
Skin Pharmacology and Physiology|October 26, 2020
Flare Size but Not Intensity Reflects Histamine-Induced ItchSylwia Lehmann, Elyne Deuring, Karsten Weller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Mast Cells Limit the Exacerbation of Chronic Allergic Contact Dermatitis in Response to Repeated Allergen ExposureVladimir-Andrey Gimenez-Rivera, Frank Siebenhaar, Carolin Zimmermann, et al.
Nature Reviews. Disease Primers|September 15, 2022
UrticariaPavel Kolkhir, Ana M Giménez-Arnau, Kanokvalai Kulthanan, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2023
The 7-day recall period version of the Urticaria Control Test-UCT7Thomas Buttgereit, Pascale Salameh, Olga Sydorenko, et al.
Clinical and Experimental Medicine|August 9, 2023
An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphomaMan Hu, Jörg Scheffel, Daniel Elieh-Ali-Komi, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2014
The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticariaTse Wen Chang, Christina Chen, Chien-Jen Lin, et al.
Immunological Reviews|May 15, 2007
Mast cells in the promotion and limitation of chronic inflammationMartin Metz, Michele A Grimbaldeston, Susumu Nakae, et al.
Pageof 26